Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Baxter
Harvard Business School
McKesson
Dow

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Andrographolide

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Andrographolide?

Andrographolide is an investigational drug.

There have been 7 clinical trials for Andrographolide. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2016.

The most common disease conditions in clinical trials are Multiple Sclerosis, Bronchitis, and Acute Disease. The leading clinical trial sponsors are Jiangxi Qingfeng Pharmaceutical Co. Ltd., University of Chile, and Universidad Austral de Chile.

There are six US patents protecting this investigational drug and thirty-three international patents.

Recent Clinical Trials for Andrographolide
TitleSponsorPhase
HMPL004-6599 Phase I Dose-escalating StudyHutchison Medipharma LimitedPhase 1
HMPL004-6599 Phase I Dose-escalating StudyNestléPhase 1
HMPL004-6599 Phase I Dose-escalating StudyNutrition Science Partners LimitedPhase 1

See all Andrographolide clinical trials

Clinical Trial Summary for Andrographolide

Top disease conditions for Andrographolide
Top clinical trial sponsors for Andrographolide

See all Andrographolide clinical trials

US Patents for Andrographolide

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Andrographolide   Start Trial Terpene derivative-based PAR1 inhibitor, preparation method thereof, and use in treatment of thrombotic diseases SHANDONG UNIVERSITY (Jinan, CN)   Start Trial
Andrographolide   Start Trial Anticancer compounds: process for their preparation and pharmaceutical compositions containing them Dr. Reddy's Research Foundation (Hyderabad, IN)   Start Trial
Andrographolide   Start Trial Compounds having anticancer activity : process for their preparation and pharmaceutical compositions containing them Dr. Reddy's Laboratories Limited (Andhra Pradesh, IN)   Start Trial
Andrographolide   Start Trial Composition of labdane diterpenes extracted from andrographis paniculata, useful for the treatment of autoimmune diseases, and alzheimer disease by activation for PPR-gamma receptors Herbal Powers Corporation (Bradenton, FL)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Andrographolide

Drugname Country Document Number Estimated Expiration Related US Patent
Andrographolide China 105732595 2035-12-22   Start Trial
Andrographolide World Intellectual Property Organization (WIPO) 2017107262 2035-12-22   Start Trial
Andrographolide Australia 5657001 1989-12-31   Start Trial
Andrographolide World Intellectual Property Organization (WIPO) 0185710 1989-12-31   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Merck
Moodys
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.